335 related articles for article (PubMed ID: 20511141)
1. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.
Sim SC; Ingelman-Sundberg M
Hum Genomics; 2010 Apr; 4(4):278-81. PubMed ID: 20511141
[TBL] [Abstract][Full Text] [Related]
2. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
[TBL] [Abstract][Full Text] [Related]
3. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-91. PubMed ID: 16719391
[TBL] [Abstract][Full Text] [Related]
4. The Human Cytochrome P450 Allele Nomenclature Committee Web Site : Submission Criteria, Procedures, and Objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-191. PubMed ID: 27699669
[TBL] [Abstract][Full Text] [Related]
5. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Gaedigk A; Ingelman-Sundberg M; Miller NA; Leeder JS; Whirl-Carrillo M; Klein TE;
Clin Pharmacol Ther; 2018 Mar; 103(3):399-401. PubMed ID: 29134625
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of cytochrome P450 and xenobiotic toxicity.
Ingelman-Sundberg M
Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
8. Genetic insight into cytochrome P450 in Chinese from the Chinese Millionome Database.
Qi G; Han C; Sun Y; Zhou Y
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):341-352. PubMed ID: 31661191
[TBL] [Abstract][Full Text] [Related]
9. CYP-nsSNP: a specialized database focused on effect of non-synonymous SNPs on function of CYPs.
Zhang T; Zhou Q; Pang Y; Wang Y; Jin C; Huo J; Liu LA; Wei D
Interdiscip Sci; 2012 Jun; 4(2):83-9. PubMed ID: 22843230
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
[TBL] [Abstract][Full Text] [Related]
12. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
Velazquez MNR; Parween S; Udhane SS; Pandey AV
Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
[TBL] [Abstract][Full Text] [Related]
13. P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.
Hart SN; Zhong XB
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):439-52. PubMed ID: 18433346
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of poor drug metabolism in greyhounds: Canine P450 oxidoreductase genetic variation, breed heterogeneity, and functional characterization.
Martinez SE; Pandey AV; Perez Jimenez TE; Zhu Z; Court MH
PLoS One; 2024; 19(2):e0297191. PubMed ID: 38300925
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM; Schwab M
Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
[TBL] [Abstract][Full Text] [Related]
16. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.
Gomes AM; Winter S; Klein K; Turpeinen M; Schaeffeler E; Schwab M; Zanger UM
Pharmacogenomics; 2009 Apr; 10(4):579-99. PubMed ID: 19374516
[TBL] [Abstract][Full Text] [Related]
19. Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes.
Fang Y; Gao N; Tian X; Zhou J; Zhang HF; Gao J; He XP; Wen Q; Jia LJ; Jin H; Qiao HL
Cell Physiol Biochem; 2018; 47(4):1604-1616. PubMed ID: 29949783
[TBL] [Abstract][Full Text] [Related]
20. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
